Diabetic Macular Edema (DME) Unknown Status Phase 3 Trials for Triamcinolone (DB00620)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00370422Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialTreatment
NCT00370669Effect of Intravitreal Bevacizumab on Clinically Significant Macular EdemaTreatment